Literature DB >> 21042718

Expression pattern of REIC/Dkk-3 in various cell types and the implications of the soluble form in prostatic acinar development.

Kai Zhang1, Masami Watanabe, Yuji Kashiwakura, Shun-Ai Li, Kohei Edamura, Peng Huang, Ken Yamaguchi, Yasutomo Nasu, Yasuyuki Kobayashi, Masakiyo Sakaguchi, Kazuhiko Ochiai, Hiroshi Yamada, Kohji Takei, Hideo Ueki, Nam-Ho Huh, Ming Li, Haruki Kaku, Yanqun Na, Hiromi Kumon.   

Abstract

The tumor suppressor REIC/Dkk-3 is a secretory protein which was originally identified to be downregulated in human immortalized cells. In the present study, we investigated the expression pattern of REIC/Dkk-3 in various cell types to characterize its physiological functions. We first examined the expression level of REIC/Dkk-3 in a broad range of cancer cell types and confirmed that it was significantly downregulated in all of the cell types. We also examined the tissue distribution pattern in a variety of normal mouse organs. Ubiquitous REIC/Dkk-3 protein expression was observed in the organs. The expression was abundant in the liver, heart and brain tissue, but was absent in the spleen and peripheral blood mononuclear cells. The immunohistochemical analyses revealed that the subcellular localization of REIC/Dkk-3 had a punctate pattern around the nucleus, indicating its association with secretory vesicles. In cancer cells stably transfected with REIC/Dkk-3, the protein was predominantly localized to the endoplasmic reticulum (ER) under observation with confocal microscopy. Because REIC/Dkk-3 was found to be abundantly expressed in the acinar epithelial cells of the mouse prostate, we analyzed the effects of recombinant REIC/Dkk-3 protein on the acinar morphogenesis of RWPE-1 cells, which are derived from human normal prostate epithelium. Statistically significant acinar growth was observed in the culture condition with 10 µg/ml REIC/Dkk-3 protein, implicating the soluble form in prostatic acinar development. Current results suggest that REIC/Dkk-3 may play a role in regulating the morphological process of normal tissue architecture through an autocrine and/or paracrine manner.

Entities:  

Mesh:

Substances:

Year:  2010        PMID: 21042718     DOI: 10.3892/ijo_00000802

Source DB:  PubMed          Journal:  Int J Oncol        ISSN: 1019-6439            Impact factor:   5.650


  17 in total

1.  Dickkopf-3, an immune modulator in peripheral CD8 T-cell tolerance.

Authors:  Maria Papatriantafyllou; Gerhard Moldenhauer; Julia Ludwig; Anna Tafuri; Natalio Garbi; Gorana Hollmann; Günter Küblbeck; Alexandra Klevenz; Sabine Schmitt; Georg Pougialis; Christof Niehrs; Hermann-Josef Gröne; Gunter J Hämmerling; Bernd Arnold; Thilo Oelert
Journal:  Proc Natl Acad Sci U S A       Date:  2012-01-17       Impact factor: 11.205

2.  Dickkopf-3 attenuates pressure overload-induced cardiac remodelling.

Authors:  Yan Zhang; Yu Liu; Xue-Hai Zhu; Xiao-Dong Zhang; Ding-Sheng Jiang; Zhou-Yan Bian; Xiao-Fei Zhang; Ke Chen; Xiang Wei; Lu Gao; Li-Hua Zhu; Qinglin Yang; Guo-Chang Fan; Wayne B Lau; Xinliang Ma; Hongliang Li
Journal:  Cardiovasc Res       Date:  2014-01-09       Impact factor: 10.787

3.  Implications of transcriptional factor, OCT-4, in human bladder malignancy and tumor recurrence.

Authors:  Peng Huang; Jie Chen; Lei Wang; Yanqun Na; Haruki Kaku; Hideo Ueki; Katsumi Sasaki; Ken Yamaguchi; Kai Zhang; Takashi Saika; Yasutomo Nasu; Masami Watanabe; Hiromi Kumon
Journal:  Med Oncol       Date:  2011-05-01       Impact factor: 3.064

4.  Dkk3 prevents familial dilated cardiomyopathy development through Wnt pathway.

Authors:  Dan Lu; Dan Bao; Wei Dong; Ning Liu; Xu Zhang; Shan Gao; Wenping Ge; Xiang Gao; Lianfeng Zhang
Journal:  Lab Invest       Date:  2015-12-07       Impact factor: 5.662

5.  A novel gene expression system strongly enhances the anticancer effects of a REIC/Dkk-3-encoding adenoviral vector.

Authors:  Masami Watanabe; Masakiyo Sakaguchi; Rie Kinoshita; Haruki Kaku; Yuichi Ariyoshi; Hideo Ueki; Ryuta Tanimoto; Shin Ebara; Kazuhiko Ochiai; Junichiro Futami; Shun-Ai Li; Peng Huang; Yasutomo Nasu; Nam-Ho Huh; Hiromi Kumon
Journal:  Oncol Rep       Date:  2013-12-31       Impact factor: 3.906

6.  Ad-REIC Gene Therapy: Promising Results in a Patient with Metastatic CRPC Following Chemotherapy.

Authors:  Hiromi Kumon; Katsumi Sasaki; Yuichi Ariyoshi; Takuya Sadahira; Shin Ebara; Takao Hiraki; Susumu Kanazawa; Hiroyuki Yanai; Masami Watanabe; Yasutomo Nasu
Journal:  Clin Med Insights Oncol       Date:  2015-03-23

7.  Pax6 regulates the expression of Dkk3 in murine and human cell lines, and altered responses to Wnt signaling are shown in FlpIn-3T3 cells stably expressing either the Pax6 or the Pax6(5a) isoform.

Authors:  Siri Forsdahl; Yury Kiselev; Rune Hogseth; Janne E Mjelle; Ingvild Mikkola
Journal:  PLoS One       Date:  2014-07-16       Impact factor: 3.240

8.  Dkk-3, a secreted wnt antagonist, suppresses tumorigenic potential and pulmonary metastasis in osteosarcoma.

Authors:  Carol H Lin; Yi Guo; Samia Ghaffar; Peter McQueen; Jonathan Pourmorady; Alexander Christ; Kevin Rooney; Tao Ji; Ramez Eskander; Xiaolin Zi; Bang H Hoang
Journal:  Sarcoma       Date:  2013-02-10

9.  Clinical significance of CD24 as a predictor of bladder cancer recurrence.

Authors:  Chunxiao Liu; Shaobo Zheng; Haiyan Shen; Kai Xu; Jie Chen; Hulin Li; Yawen Xu; Abai Xu; Binshen Chen; Haruki Kaku; Yasutomo Nasu; Hiromi Kumon; Peng Huang; Masami Watanabe
Journal:  Oncol Lett       Date:  2013-05-21       Impact factor: 2.967

10.  Adenovirus-mediated REIC/Dkk-3 gene therapy: Development of an autologous cancer vaccination therapy (Review).

Authors:  Masami Watanabe; Yasutomo Nasu; Hiromi Kumon
Journal:  Oncol Lett       Date:  2013-12-27       Impact factor: 2.967

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.